This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Assistance Publique - Hopitaux De Paris (Aphp), National Institute of Health and Medical Research, Université De Paris. Active years: 2026.
Company Filing History:
1 out of 77 
1 out of 1,853 
1 out of 68 
Years Active: 2026
Title: Smail Hadj-Rabia: Innovator in Wound Healing
Introduction
Smail Hadj-Rabia is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the area of wound healing for patients suffering from ectodermal dysplasias. His innovative approach has led to the development of a unique method that promotes healing in affected individuals.
Latest Patents
Hadj-Rabia holds a patent for "Methods and compositions for promoting wound healing in a subject suffering from ectodermal dysplasias." This invention involves administering a therapeutically effective amount of a compound that restores the activity of p63. The research demonstrated that the application of compounds such as STIMA-1 and PRIMA-1Met can significantly enhance the differentiation of keratinocytes in patients. The results showed that the mutated activity of p63 is restored, leading to improved proliferation and differentiation of keratinocytes.
Career Highlights
Throughout his career, Smail Hadj-Rabia has worked with prestigious institutions, including Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. His work has been instrumental in advancing the understanding and treatment of ectodermal dysplasias.
Collaborations
Hadj-Rabia has collaborated with notable colleagues, including Daniel Aberdam and Edith Aberdam. Their joint efforts have contributed to the success of his research and the development of effective treatments for patients.
Conclusion
Smail Hadj-Rabia's innovative work in promoting wound healing represents a significant advancement in medical science. His contributions have the potential to improve the quality of life for many individuals suffering from ectodermal dysplasias.